Email Print this page Bookmark this page

Presentations

This video demonstrates the importance of instructing your patients on how to properly insert LACRISERT®. It also provides a visual simulation of the proper insertion technique.

2009 Lacrisert Presentation
Marguerite B. McDonald, MD, FACS

Marguerite B. McDonald, MD, FACS, is a clinical professor of ophthalmology at New York University in New York, an adjunct clinical professor of ophthalmology at Tulane University Health Sciences Center in New Orleans, Louisiana, and a surgeon at the Ophthalmic Consultants of Long Island in Lynbrook, New York.

An overview of LACRISERT® and dry eye syndrome (DES).

Studies and results regarding the use of LACRISERT® in the treatment of DES.

The established clinical and safety profiles of LACRISERT® and its comparison to artificial tears.

A presentation outlining the insertion of LACRISERT® into the eye.

Case study 1 - a 59 year old woman with worsening DES.

Case study 2 - a 52 year old of female with ocular burning and dryness.

Dr McDonald demonstrates the insertion of LACRISERT® on herself.

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807